In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: A controlled study with vancomycin

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1574-1577

  Prieto, J ^a   Aguilar, L ^b   Gimenez M J ^b   Toro, D ^a   Gomez Lus M L ^a   Dal Re R ^b   Balcabao, I P ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

EID: 0031807596     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1574     Document Type: Article

References (27)

1. Aguilar, L., M. Martín, I. P. Balcabao, M. L. Gómez-Lus, R. Dal-Ré, and J. Prieto. 1997. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens. Antimicrob. Agents Chemother. 41:1403-1405.
2. Brook, I. 1989. Inoculum effect. Rev. Infect. Dis. 11:361-368.
3. Brumfitt, W., and J. Hamilton-Miller. 1989. Methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 320:1188-1196.
4. Cantoni, L., A. Wenger, M. P. Glauser, and J. Bille. 1989. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J. Infect. Dis. 159:989-993.
5. Chambers, H. F., and C. J. Hackbarth. 1987. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 31: 1982-1988.
6. Cox, A. L., J. M. J. M. Meewis, and R. Horton. 1989. Penetration into lung tissue after intravenous administration of amoxycillin/clavulanate. J. Antimicrob. Chemother. 24(Suppl. B):87-91.
7. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
8. Dámaso, D., M. Moreno-López, and R. M. Daza (ed.). 1984. Vancomicina, p. 377-397. In Antibioticos y quimioterápicos antibacterianos. Uso clínico. Grutesa, Madrid, Spain.
9. Firsov, A. A., S. N. Vostrov, A. A. Shevchenko, and G. Cornaglia. 1997. Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model. Antimicrob. Agents Chemother. 41:1281-1287.
10. Franciolli, M., J. Bille, M. P. Glauser, and P. Moreillon. 1991. β-Lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 163:514-523.
11. Garvev, G. H., and H. C. Neu. 1978. Infective endocarditis: an evolving disease. A review of endocarditis at the Columbia Presbyterian Medical Center 1968-1973. Medicine 57:105-127.
12. Hartman, B. J., and A. Tomasz. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85-92.
13. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
14. Josefson, D. 1997. Vancomycin resistant Staphylococcus aureus reported. Br. Med. J. 315:700.
15. Kloos, W. E., and T. L. Bannerman. 1995. Staphylococcus and Micrococcus, p. 282-298. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
16. Kucers, A., and N. M. Bennett (ed.). 1979. Vancomycin, p. 646-653. In The use of antibiotics: a comprehensive review with clinical emphasis, 3rd ed. William Heinemann Medical Books Ltd., London, United Kingdom.
17. Martín, M., L. Aguilar, I. P. Balcabao, M. L. Gómez-Lus, R. Dal-Ré, and J. Prieto. 1997. In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzue β-lactamasc activity. J. Antimicrob. Chemother. 39:290-292.
18. Moreillon, P. 1994. The efficacy of amoxycillin/clavulanate (Augmentin®) in the treatment of severe staphylococcal infections. J. Chemother. VI(Suppl. 2):51-57.
19. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Nicolas, M. H., M. D. Kitsis, and A. Karim. 1993. Sterilisation par 2 grammes d'Augmentin des urines infectées a Staphylococcus aureus resistant a la meticillin. Méd. Mal. Infect. 23:82-94.
21. O'Callagham, C., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
22. Palmer, S. M., and M. J. Rybak. 1997. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots. J. Antimicrob. Chemother. 39:515-518.
23. Panlilio, A. L., D. H. Culver, R. P. Gaynes, S. Banerjee, T. S. Henderson, J. S. Tolson, and W. J. Martone. 1992. Methicillin-resistant Staphylococcus aureus in U.S. hospitals. 1975-1991. Infect. Control Hosp. Epidemiol. 13:582-586.
24. Quintiliani, R., Jr., and P. Courvalin. 1995. Mechanisms of resistance to antimicrobial agents, p. 1308-1326. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
25. Rolinson, G. N. 1994. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993. J. Chemother. 6:283-318.
26. Staniforth, D. H., D. Jackson, R. Horton, and B. Davies. 1984. Parenteral Augmentin: pharmacokinetics. Int. J. Clin. Pharmacol. Ther. Toxicol. 22: 430-434.
27. Washburn, R. G., and D. T. Durack. 1981. Efficacy of ampicillin plus a β-lactamase inhibitor (CP 45,899) in experimental endocarditis due to Staphylococcus aureus. J. Infect. Dis. 144:237-243.